Phase II trial in patients with treatment-resistant partial seizures.
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2011
At a glance
- Drugs ICA 105665 (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors Neusentis
- 22 Mar 2011 Planned number of patients changed from 120 to 60.
- 05 May 2010 New trial record